VINCRISTINE, IRINOTECAN AND TEMOZOLOMIDE TREATMENT FOR RECURRENT/PROGRESSIVE PEDIATRIC SOLID TUMORS

被引：0
|
作者：
Kebudi, R. [1 ]
Bay, S. Buyukkapu [1 ]
Cakir, F. B. [2 ]
Gorgun, O. [1 ]
Koc, B. [1 ]
Zulfikar, B. [1 ]
Agaoglu, F. Yaman [3 ]
Darendeliler, E. [3 ]
机构：
[1] Istanbul Univ, Cerrahpasa Med Fac, Pediat Hematol Oncol, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Med, Pediat Hematol Oncol, Istanbul, Turkey
[3] Istanbul Univ, Inst Oncol, Radiat Oncol, Istanbul, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-053
引用
收藏
页码：S158 / S159
页数：2
相关论文
共 50 条
  • [31] Topotecan in pediatric patients with recurrent and progressive solid tumors: A pediatric oncology group phase II study
    Nitschke, R
    Parkhurst, J
    Sullivan, J
    Harris, MB
    Bernstein, M
    Pratt, C
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (04) : 315 - 318
  • [32] Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory neuroblastoma.
    Zhu, Jia
    Zhen, Zijun
    Wang, Juan
    Chen, Tingting
    Lu, Suying
    Sun, Feifei
    Huang, Junting
    Que, Yi
    Zhang, Lian
    Zhang, Yizhuo
    Sun, Xiaofei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
    Raciborska, Anna
    Bilska, Katarzyna
    Drabko, Katarzyna
    Chaber, Radoslaw
    Pogorzala, Monika
    Wyrobek, Elzbieta
    Polczynska, Katarzyna
    Rogowska, Elzbieta
    Rodriguez-Galindo, Carlos
    Wozniak, Wojciech
    PEDIATRIC BLOOD & CANCER, 2013, 60 (10) : 1621 - 1625
  • [34] Phase 1 study of pevonedistat (MLN4924) in combination with temozolomide (TMZ) and irinotecan (IRN) in pediatric patients with recurrent or refractory solid tumors (ADVL1615).
    Foster, Jennifer
    Muscal, Jodi Ann
    Minard, Charles G.
    Liu, Xiaowei
    Reid, Joel M.
    Berg, Stacey L.
    Fox, Elizabeth
    Weigel, Brenda
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] IRINOTECAN AND TEMOZOLAMIDE AS EFFECTIVE SCHEDULE IN PROGRESSIVE AND THERAPY RESISTANT NEUROBLASTOMA - EXPERIENCE OF POLISH PEDIATRIC SOLID TUMORS GROUP
    Wieczorek, A.
    Stypinska, M.
    Hennig, M.
    Wieczorek, M.
    Januszkiewicz-Lewandowska, D.
    Zubowska, M.
    Peszynska-Bialczynska, K.
    Sobol-Milewska, G.
    Ussowicz, M.
    Balwierz, W.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S337 - S337
  • [36] OUTCOMES IN PEDIATRIC MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS UTILIZING TEMOZOLOMIDE, BEVACIZUMAB, AND IRINOTECAN
    Reel, Sarah
    Smiley, Natasha Pillay
    Hummel, Trent
    Lane, Adam
    NEURO-ONCOLOGY, 2023, 25
  • [37] A pilot clinical study of oral irinotecan HCl (VAL-413) in patients with recurrent pediatric solid tumors
    Bacha, Jeffrey A.
    Brown, Dennis
    Geller, James I.
    Oesterheld, Javier E.
    McManus, Meghann
    Kanekal, Sarath
    Leggas, Markos
    Lopez, Lorena
    Sankar, Neil
    Yam, Noymi
    Wagner, Lars M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] COMBINATION THERAPY WITH VINCRISTINE, IRINOTECAN, AND TEMOZOLOMIDE IN CENTRAL NERVOUS SYSTEM MALIGNANCIES
    Gibson, Amber
    Bavle, Abhishek
    Gross, Naina
    Gavula, Theresa
    McNall, Rene
    NEURO-ONCOLOGY, 2018, 20 : 68 - 68
  • [39] A Modified Protocol with Vincristine, Topotecan, and Cyclophosphamide for Recurrent/Progressive Ewing Sarcoma Family Tumors
    Kebudi, Rejin
    Cakir, Fatma Betul
    Gorgun, Omer
    Agaoglu, Fulya Yaman
    Darendeliler, Emin
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2013, 30 (03) : 170 - 177
  • [40] Irinotecan for pediatric solid tumors: The Memorial Sloan-Kettering experience
    Cosetti, M
    Wexler, LH
    Calleja, E
    Trippett, T
    LaQuaglia, M
    Huvos, AG
    Gerald, W
    Healey, JH
    Meyers, PA
    Gorlick, R
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (02) : 101 - 105
12345